Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
43 Cards in this Set
- Front
- Back
Where do NT peptides get made?
|
Cell Body
|
|
Where do low molecular weight NTs get synthesized?
|
Axon terminal
|
|
What triggers NT release?
|
1. AP causes Ca release
2. Ca causes NT release |
|
Speed of
Ionotropic receptors Metabotropic receptors(G-protein linked) |
1. Fast Acting
2. Slow Acting |
|
3 ways to remove NTs from the synaptic cleft?
|
1. Degradation
2. diffuse out of cleft 3. reuptake (pharmaceutical target) |
|
Ionotropic Receptor Signalling Characteristics, speed and channels?
|
1. Fast Acting
2. Downstream effects; a. Open K or Cl channels = Hyperpolarization b. Open Na or Ca channels = depolarization |
|
Metabotropic Receptor Signalling, speed/effects?
|
1. Slow Acting
2. Down Stream Effects, affect ion channels, NTs or gene transcription |
|
What are the major downstream signal transduction pathways?(3)
|
1. cAMP and cGMP
2. Ca 3. IP3 and DAG |
|
What does G-protein coupled opening of K channels do?
|
Hyperpolarize the cell and make the neuron less excitable
|
|
What makes an NT(2)?
|
1. Made, stored and released in the neuron
2. Able to initiate some post synaptic event |
|
What do NTs do?
Excitatory and inhibitory? |
1. They change the membrane potential of the postsynaptic cell
2. Increase Na or Ca permeability 3. Increase Cl or K permeability |
|
Ligand gated Ion channels(ionotropic) mediate? and G protein linked(metabotropic) receptors mediate?
|
1. The fast ( nicotinic, GABAa, NMDA, AMPA)
2. The slower catecholamines, adrenergic, dopamine, 5HT, opiate and muscarinic |
|
The three types of NTs?
|
1. Low molecular weight; Amino acids, ACh, and biogenic amines
2. High molecular weight peptides. 3. Retrograde NT, NO and cannabinoids |
|
Acetylcholine characteristics(4)
|
1. Low weight
2. Synthesis from acetyl CoA and choline 3. Degradation by acetylcholinesterase 4. Choline reupatke into presynaptic cell |
|
Nicotinic and muscarinic receptors?
|
1. Ionotropic excitatory, at NMJ and autonomic ganglia(nicotine is fast)
2. Metabotropic, Gprotein forming IP3 or lowering cAMP |
|
Myasthenia Gravis(3 + tx)
|
1. Postsynaptic NMJ Disorder
2. ACh receptor antibodies = progressive muscle weakness 3. Gets worse with muscle use 4. ACh Inhibitors to get better |
|
Lambert Eaton Syndrome(3)
|
1. Presynaptic NMJ disorder
2. Ca channel antibodies = . No ACh release Eaton eats Ca channels |
|
Anticholinergic drugs do what?(3)
|
1. Control saliva and gastric acid(antacid)
2. Slow gut motility(anti-Diarrhea) 3. Prevent vomitting(anti emetic) Triple AAA |
|
Glutamate characteristics(3)
|
1. Major excitatory NT
2. Low weight 3. Degradation |
|
3 types of glutamate receptors
|
1. NMDA and AMPA, and Kalinate
|
|
Glutamate action on AMPA and NMDA receptors ...LTP
|
1. NMDA intially blocked by Mg
2. AMPA activation depolarizes NMDA 3. Mg removal and pore opens 4. Na and Ca enter the cell |
|
Glu and neurotoxicity
|
1. Low O2
2. no ATP 3. Glu increase in cleft 4. Increase in Ca intracellular 5. Phospholipase activation 6. cell death |
|
Glu clinical(5)LASSE
|
1. Learning/memory
2. ALS 3. Seizures 4. Schizos 5. Excitotoxicity LASSE sniffs glue |
|
Glu and LTP
|
Glu firing changes the synapse and helps record memories using NMDA and increased AMPA receptors
|
|
GABA charcteristics(2)
|
1.Major inhibitory NT
2. AA |
|
GABA-a
GABA-b |
a = ionotropic = Cl
b = metaBotropic = K |
|
GABA Drugs
|
1. Barbituates
2. Benzos |
|
3 GABA general effects
|
1. Enhanced GABA is sedative, hypnotic, anticonvulsant
|
|
Glycine(2)
|
1. Inhibitory in the spinal cord
2. Ionotropic receptor - opens Cl channels |
|
The 3 catecholamines
|
Dopamine, norepi,epi
|
|
Dopamine receptors(3)
|
1. both Metabodopic
2. D1 = +cAMP 3. D2 = -cAMP |
|
Dopamine neurons areas(3)
|
1. Substantia Nigra
2. Ventral Tegmentum 3. Arcuate nucleus of hypothalamus |
|
Parkinson's
|
Degeneration of Nirgro-striatal dopamine neurons
|
|
DA and Schizophrenia
|
Due to elevated dopaminergic transmission. So we block the D2 receptors
|
|
Norepinephrine(3)
|
1. Biogenic AA
2. alpha and beta receptors |
|
Norepi nuclei in the brainstem
|
1. Locus Ceruleus
|
|
Norepi receptors(3)
|
1. Alpha 1 - vasoC
3. Beta 1 - HR and force 4. Beta 2 - BronchoD |
|
Norepi clinical(2)
|
1. Depression
2. Bipolar 2 |
|
Serotonin Characteristics(3)
|
1. Indolamine
3. Sleep/wake, pain, apetite, mood |
|
Serotonin location
|
Raphe nuclei
|
|
Serotonin Clinical general (2)
|
1. Depression
2. Migraines now that serotonin's gone I have headaches |
|
Histamine Characteristics(3)
|
1. Biogenic Amine
2. Excitatory = Arousal and attention in brain Sgt Histamine bring the brain to attention! |
|
Opiate Peptides(2 types)
|
1. Beta endorphin
2. Enkephalin |